SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production is a research paper published in Journal of Clinical Investigation (2023). On theSindex it has a DataRank of 0. It has been cited 35 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: K08CA237822
American Society for Clinical Oncology
Grant: 13170
American Cancer Society
Grant: IRG1815861
Washington University Radiation Oncology
Grant: NA
NIH
Grant: P30CA091842-21S2,R01CA181745
NIH
Grant: K22CA237839
NCI NIH HHS
Grant: P30 CA091842
NCI NIH HHS
Grant: U54 CA274318
NCI NIH HHS
Grant: R01 CA181745
National Institutes of Health
Grant: 5K08CA237822-03
Mechanisms of radiation-induced tumor cell death and survival in cervical cancer
National Institutes of Health
Grant: 5P30CA091842-05
Core--Pharmacology Facility
National Institutes of Health
Grant: 5K22CA237839-02
HPV alternative splicing in cervical cancer radiation response
National Institutes of Health
Grant: 5R01CA181745-07
Optimizing radiation therapy through the manipulation of glutamine metabolism
Fields of Study
MeSH Terms
Keywords